| Financial Year |
March 31 2023 |
| Monetary Funds |
868,836,214.69 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
68,548,018.21 |
| Accounts Receivable |
1,986,315,641.20 |
| Advances to Suppliers |
222,360,408.48 |
| Other Receivables |
207,028,487.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
28,771,270.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,084,553.08 |
| Total Current Assets |
6,886,945,874.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
878,105,278.93 |
| Investment Properties |
29,115,986.42 |
| Fixed Assetes |
36,033,304.49 |
| Under-construction Projects |
107,861,426.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
222,162,858.65 |
| R&D expenses |
-- |
| Goodwill |
4,243,048.08 |
| Long-Term Deferred and Prepaid Expenses |
5,436,197.06 |
| Deferred Income Tax Assets |
808,558,449.66 |
| Other Non-Current Assets |
11,690,378.98 |
| Sub-Total of Non-Current Assets |
2,159,895,341.75 |
| Total Assets |
9,046,841,216.34 |
| Short-Term Loans |
1,745,100,271.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,097,129,139.84 |
| Accounts Payable |
2,120,862,839.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,872,250.55 |
| Taxes Payable |
239,333,570.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,311,866,216.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,746,485.01 |
| Other Current Liabilities |
21,407,173.80 |
| Sub-Total of Current Liabilities |
7,838,096,320.84 |
| Long-term Loans |
192,631,566.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
220,860,412.05 |
| Total Liabilities |
8,058,956,732.89 |
| Paid-In Capital(Or Share Stock) |
546,269,628.00 |
| Capital Surplus |
2,206,289,103.96 |
| Surplus Reserve |
178,587,442.87 |
| LESS:Treasury Stock |
49,212,574.80 |
| Undistributed Profits |
-1,999,960,332.46 |
| Minority Stockholder's Interest |
27,676,952.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
960,207,530.81 |
| Owner's Equity（Stockholder's Equity） |
987,884,483.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,046,841,216.34 |
